Kiniksa Pharmaceuticals International (KNSA) FCF Margin (QoQ) (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.43 Bn | 43.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.72 Bn | 40.07 Bn | 2.15 Bn |
| 3 | Zoetis | 32.38 Bn | 30.70 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.14 Bn | 5.61 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -425.00 |
| Mar 31, 2026 | -163.00 |
| Dec 31, 2025 | 644.00 |
| Sep 30, 2025 | 67.00 |
| Jun 30, 2025 | 18.00 |
| Mar 31, 2025 | 443.00 |
| Dec 31, 2024 | 1,526.00 |
| Sep 30, 2024 | -322.00 |
| Jun 30, 2024 | 44.00 |
| Mar 31, 2024 | -609.00 |
| Dec 31, 2023 | -1,846.00 |
| Sep 30, 2023 | 3,070.00 |
| Jun 30, 2023 | -330.00 |
| Mar 31, 2023 | -1,005.00 |
| Dec 31, 2022 | -5,461.00 |
| Sep 30, 2022 | 9,100.00 |
| Jun 30, 2022 | 7,751.00 |
| Mar 31, 2022 | 670.00 |
| Dec 31, 2021 | 12,955.00 |
| Sep 30, 2021 | 26,188.00 |